Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Tracy Downs
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
© 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Highlighting Bias and Barriers in Urological Care and Prostate Cancer Research - Linda L. McIntire & Tracy M. Downs
Read the Full Video Transcript Matthew Cooperberg: Good morning. I'm Matt Cooperberg from UCSF in San Francisco. It's a pleasure to welcome you to another edition of the UroToday Localized Prostate Cancer Center of Excellence, live from AUA 2023 in Chicago.
Supporting Black voices in urology
At Nature Reviews Urology, we have pledged to strive towards improving diversity in our field. As a step towards this goal, this Viewpoint presents the experiences of 10 Black urologists. Their stories illustrate the importance of perseverance and emphasize the essential role of community and mentorship to raise up our peers and colleagues, to support and encourage Black urologists and lead to a more diverse field of urology in the future. Fig. 1: Some of our contributors. References 1.
Prostate Cancer: What African-American Men Need to Know
A recent report from the UW Cancer Health Disparities Initiative (CHDI) had the shocking news that African-American men in Wisconsin are 71 percent more likely to be diagnosed with prostate cancer and die of it more often than white men. Dr. Tracy Downs, UW Health cancer surgeon and current president of the national association of black urologists, the R. Frank Jones Urological Society, offers his perspective on these numbers.
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018 | Nature Reviews Urology
Abstract Blue light cystoscopy (BLC) with hexaminolevulinate (HAL) during transurethral resection of bladder cancer improves detection of non-muscle-invasive bladder cancer (NMIBC) and reduces recurrence rates. Flexible BLC was approved by the FDA in 2018 for use in the surveillance setting and was demonstrated to improve detection.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Tracy
Contact Tracy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack